Trial Profile
Prescriber compliance with renal function monitoring in patients taking dabigatran (Pradaxa)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2016
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Embolism and thrombosis
- Focus Therapeutic Use
- 07 Mar 2016 New trial record